LONDON, Nov. 8 /PRNewswire-FirstCall/ -- SkyePharma PLC announces today that the Company’s Chief Executive, Michael Ashton, will make a presentation at the SG Cowen & Co. 6th Annual Global Health Care Conference at the Hilton Diagonal Mar Hotel in Barcelona, Spain. Mr. Ashton will deliver his presentation on Thursday, November 10, 2005 at 10.55 a.m. (CET). Investors may access a live webcast of the presentation at www.skyepharma.com under the Investor Relations tab.
About SkyePharma PLC
SkyePharma PLC uses its world-leading drug delivery technology to develop easier-to-use and more effective formulations of drugs. The majority of challenges faced in the formulation and delivery of drugs can be addressed by one of the Company’s proprietary technologies in the areas of oral, injectable, inhaled and topical delivery, supported by advanced solubilisation capabilities. For more information, visit www.skyepharma.com.
For further information please contact: SkyePharma PLC +44 207 491 1777 Michael Ashton, Chief Executive Officer Peter Laing, Director of Corporate Communications 44 207 491 5124 Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000 Tim Anderson / Mark Court / Rebecca Skye Dietrich
SkyePharma PLC
CONTACT: Michael Ashton, Chief Executive Officer, or Peter Laing, Directorof Corporate Communications, both at +44 207 491 5124, or investor, SandraHaughton, +1 212 753 5780, all for SkyePharma PLC, or Tim Anderson, MarkCourt, Rebecca Skye Dietrich, +44 207 466 5000, all for BuchananCommunications
Web site: http://www.skyepharma.com/
